11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Pulmonary Hypertension
Interventions
DRUG

11C-acetate

For each PET/CT imaging session subjects will receive a 15-25 millicurie intravenous injection of 11C-acetate

DRUG

[18F]Fluoro-2-deoxy-2-D-glucose

For each PET/CT imaging session subjects will receive a 10 millicurie injection of 18F-FDG

OTHER

Cardiac MRI

Cardiac MRI is performed at 6 months to measure any change in structure and function of the treatment groups.

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

University of Maryland

OTHER

collaborator

Yale University

OTHER

collaborator

Washington University School of Medicine

OTHER

collaborator

The Cardiovascular Medical Research and Education Fund

OTHER

lead

University of Pennsylvania

OTHER

NCT01917136 - 11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension | Biotech Hunter | Biotech Hunter